Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Propel BioVentures is a venture capital firm dedicated to investing in innovative life science and biotechnology companies. The firm focuses on identifying and supporting early-stage and growth-stage ventures that are developing breakthrough therapeutics, medical devices, and diagnostic tools. By providing both capital and strategic operational guidance, Propel BioVentures aims to accelerate the development of technologies that address significant unmet medical needs. The firm's leadership team consists of experienced investment professionals and industry experts with a track record of building successful healthcare companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Propel Ventures.